KIF2C expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.68669522793152E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.19769999995523E-06 |
Normal-vs-Stage2 |
8.979600E-04 |
Normal-vs-Stage3 |
7.24489999992528E-07 |
Normal-vs-Stage4 |
2.96129999965977E-07 |
Stage1-vs-Stage2 |
3.385400E-01 |
Stage1-vs-Stage3 |
8.641800E-03 |
Stage1-vs-Stage4 |
1.164970E-04 |
Stage2-vs-Stage3 |
2.143600E-01 |
Stage2-vs-Stage4 |
1.758660E-03 |
Stage3-vs-Stage4 |
1.749670E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.54950496877859E-11 |
Normal-vs-AfricanAmerican |
4.844800E-03 |
Normal-vs-Asian |
1.509760E-01 |
Caucasian-vs-AfricanAmerican |
2.584400E-02 |
Caucasian-vs-Asian |
4.427400E-01 |
AfricanAmerican-vs-Asian |
2.869400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.15579834170899E-11 |
Normal-vs-Female |
1.46740000039891E-07 |
Male-vs-Female |
7.120000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.618100E-03 |
Normal-vs-Age(41-60Yrs) |
2.0693000002403E-07 |
Normal-vs-Age(61-80Yrs) |
6.59699961325089E-10 |
Normal-vs-Age(81-100Yrs) |
1.123880E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.256200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.820000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.240380E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.939200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.305600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.286150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.017600E-02 |
Normal-vs-Grade 2 |
1.49659999948426E-07 |
Normal-vs-Grade 3 |
5.85920001405782E-09 |
Normal-vs-Grade 4 |
1.08980000002035E-06 |
Grade 1-vs-Grade 2 |
4.187700E-02 |
Grade 1-vs-Grade 3 |
2.995800E-04 |
Grade 1-vs-Grade 4 |
2.43279999999624E-05 |
Grade 2-vs-Grade 3 |
4.757700E-03 |
Grade 2-vs-Grade 4 |
1.835770E-04 |
Grade 3-vs-Grade 4 |
3.317400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.799100E-04 |
Normal-vs-ccB subtype |
1.65409996810695E-09 |
ccA subtype-vs-ccB subtype |
2.91389999995673E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.03620000357907E-08 |
Normal-vs-N1 |
6.752800E-04 |
N0-vs-N1 |
7.003000E-04 |
|
|